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Abstract
Recent results indicate that genome-wide association studies (GWAS) have the potential to explain much of the heritability
of common complex phenotypes, but methods are lacking to reliably identify the remaining associated single nucleotide
polymorphisms (SNPs). We applied stratified False Discovery Rate (sFDR) methods to leverage genic enrichment in GWAS
summary statistics data to uncover new loci likely to replicate in independent samples. Specifically, we use linkage
disequilibrium-weighted annotations for each SNP in combination with nominal p-values to estimate the True Discovery
Rate (TDR= 12FDR) for strata determined by different genic categories. We show a consistent pattern of enrichment of
polygenic effects in specific annotation categories across diverse phenotypes, with the greatest enrichment for SNPs
tagging regulatory and coding genic elements, little enrichment in introns, and negative enrichment for intergenic SNPs.
Stratified enrichment directly leads to increased TDR for a given p-value, mirrored by increased replication rates in
independent samples. We show this in independent Crohn’s disease GWAS, where we find a hundredfold variation in
replication rate across genic categories. Applying a well-established sFDR methodology we demonstrate the utility of
stratification for improving power of GWAS in complex phenotypes, with increased rejection rates from 20% in height to
300% in schizophrenia with traditional FDR and sFDR both fixed at 0.05. Our analyses demonstrate an inherent stratification
among GWAS SNPs with important conceptual implications that can be leveraged by statistical methods to improve the
discovery of loci.
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Introduction
Complex traits are generally influenced by many genes with small
individual effects [1]. This ‘polygenic’ architecture has been difficult
to characterize. While Genome-wide association studies (GWAS)
[2] have successfully identified thousands of trait-associated single
nucleotide polymorphisms (SNPs) [3], even when considered in
aggregate, these SNPs explain small portions of the trait heritability
[4]. Recent results indicate that GWAS have the potential to explain
much of the heritability of common complex phenotypes [5,6], and
more SNPs are likely to be identified in larger samples [7].
However, there are few methods available for identifying more of
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the SNPs likely to be associated with phenotypes without increasing
the sample size, as recognized by recent European and US calls for
new statistical genetics methods. The crucial issue is that for most
complex traits a large number of SNPs have too small an effect to
pass standard GWAS significance thresholds given current sample
sizes. We present results suggesting new analytical approaches for
GWAS will uncover more of the polygenic effects in complex
disorders and traits. We hypothesize that all SNPs in a GWAS are
not exchangeable, but come from pre-determinable categories with
different distributions of effects. This implies that some categories of
SNPs are enriched, i.e. are more likely to be associated with a
phenotype than others. This information can be used to calculate
the category-specific True Discovery Rate (TDR), or the expected
proportion of correctly rejected null hypotheses [8]. SNPs from
enriched SNP categories will have an increased TDR for a given
effect size, or equivalently, for a given nominal p-value. Stratified
False Discovery Rate (sFDR) methods [9] provide an established
framework for demonstrating the utility of using enriched genic
categories to increase power to discover SNPs likely to replicate in
independent samples. Previous work has applied sFDR and related
methods to GWAS data stratified by candidate regions determined
through prior linkage analysis and/or candidate gene studies
[10–12] and specific biological pathways related to disease etiology
[13]. Others have considered stratification by genome annotations
in linkage analysis [14] and Bayesian association analyses [15],
demonstrating the utility of this approach for improving power and
FDR based discovery where reliable, pre-determinable strata exist.
It has been suggested that variation in and around genes
harbors more polygenic effects [6,16]. However, the particular
gene elements (i.e., intron, exon, UTRs) containing these variants
and the distribution of effect sizes in GWAS have been left to
extrapolation and speculation. Further, SNPs in and around genes
have been shown to explain more variation [6] and replicate at
higher rates [16] than intergenic SNPs. These studies, however,
did not parse genic regions down to specific genic elements. We
here hypothesize that SNPs in regulatory and coding elements of
protein coding genes will show an enrichment of polygenic effects
relative to intronic and intergenic SNPs which will be reflected in
an increased estimated TDR and empirically confirmed through
improved replication rate across independent samples.
The association signal of a SNP tested in GWAS is a surrogate
for, or ‘tags,’ the potential effects of many other variants. Thus,
any of a number of ‘tagged’ variants could underlie the observed
association signal. Focusing on the tag SNPs only, without
systematically capturing the underlying causal variants within a
‘tagged’ linkage block, limits the functional inferences that can be
drawn from GWAS. By incorporating the correlation between
SNPs (linkage disequilibrium; LD) we expect a stronger and more
consistent differentiation of enrichment among genic annotation
categories. In the current study, we use an LD-weighted scoring
algorithm that allows quantification of the properties of multi-locus
LD structure implicitly captured by each tag SNP to our
enrichment analysis. These categories can be leveraged to create
strata for established sFDR approaches.
We employ a model free strategy to identify enriched strata
among phenotypes based on GWAS summary statistics. We first
calculate the relative enrichment in different genic elements, using
the category-specific empirical cumulative distribution function
(cdf) of the nominal p-values after controlling for estimated
genomic inflation. For each nominal p-value threshold an estimate
of the category-specific TDR=12FDR is obtained from these
empirical cdfs. This analysis is implemented on summary p-values
from ten published GWAS meta-analyses studying 14 phenotypes.
We then use the sub-study GWAS in Crohn’s disease to test if the
estimated increased TDR translates to improved replication rates,
showing that for a given replication rate the nominal p-value
threshold is 100 times larger for the most enriched genic category
compared to the intergenic category. Finally, using an established
sFDR framework we demonstrate the utility of leveraging enriched
categories for improving power to detect SNPs likely to replicate,
i.e., to reject more null hypotheses for a fixed FDR.
Results
LD-Based Enrichment of Genic Elements in Height
Under multiple testing paradigms such as GWAS, quantitative
estimates of likely true associations can be estimated from the
distributions of summary statistics [17,18]. A common method for
visualizing the enrichment of statistical association relative to that
expected under the global null hypothesis is through Q-Q plots of
the nominal p-values resulting from GWAS. Under the global null
hypothesis the theoretical distribution is uniform on the interval
[0,1]. Thus, the usual Q-Q curve has as the y-coordinate the
nominal p-value, denoted by ‘‘p’’, and the x-coordinate the value
of the empirical cdf at p, which we denote by ‘‘q’’. As is common
in GWAS, we instead plot 2log10 p against the 2log10 q to
emphasize tail probabilities of the theoretical and empirical
distributions. In such plots, enrichment results in a leftward shift
in the Q-Q curve, corresponding to a larger fraction of SNPs with
nominal 2log10 p-value greater than or equal to a given threshold
(see Material and Methods).
The stratified Q-Q plot for height (Figure 1) shows a clear
variation in enrichment across genic annotation categories. The
separation between the curves for different categories is enhanced
when using LD-weighted genic annotation categories in compar-
ison to non LD-weighted positional categories (Figure S3). The
parallel shape of these curves is likely caused by the significant but
imperfect correlation among categories due to the non-exclusive
nature of the annotation scoring (Figure S2).
An earlier departure from the null line (leftward shift) suggests a
greater proportion of true associations, for a given nominal p-value.
Author Summary
Modern genome-wide association studies (GWAS) have
failed to identify large portions of the genetic basis of
common, complex traits. Recent work suggested this
could be because many genetic variants, each with
individually small effects, compose their genetic architec-
ture, limiting the power of GWAS. Moreover, these variants
appear more abundantly in and near genes. Using genome
annotations, summary statistics from several of the largest
GWAS, and established statistical methods for quantifying
distributions of test statistics, we show a consistency
across studies. Namely, we show that, across all assessed
traits, the test statistics resulting from SNPs that are related
to the 59 UTR of genes show the largest abundance of
associations, while SNPs related to exons and the 39UTR
are also enriched. SNPs related to introns are only
moderately enriched, and intergenic SNPs show a deple-
tion of associations relative to the average SNP. This
enrichment corresponds directly to increased replication
across independent samples and can be incorporated a
priori into statistical methods to improve discovery and
prediction. Our results contribute to on-going debates
about the functional nature of the genetic architecture of
complex traits and point to avenues for leveraging existing
GWAS data for discovery in future GWA and sequencing
studies.
Differential Enrichment among SNP Categories
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The divergence of the curves for different categories implies that the
proportion of non-null effects varies considerably among annotation
categories of genic elements. For example, the proportion of SNPs in
the 59UTR category reaching a significance level of2log10(p).10 is
roughly 10 times greater than for all SNPs and 50–100 times greater
than for intergenic SNPs.
Polygenic Enrichment across Diverse Phenotypes
Recently Yang et al [19] demonstrated that an abundance of
low p-values beyond what is expected under null hypotheses in
GWAS, but not necessarily reaching stringent multiple compar-
ison thresholds, often attributed to ‘spurious inflation,’ is also
consistent with an enrichment of true ‘polygenic’ effects [19]. The
prevalence of enrichment below the established genome-wide
significance threshold of p,561028 (2log10(p).7.3;) in height
(Figure 2A) is consistent with their hypotheses and strongly
suggests that current GWAS do not capture all of the additive
‘tagged variance’ in this phenotype. Importantly, this enrichment
varies across genic annotation categories.
The enrichment patterns among annotation categories are
consistent across phenotypes, including schizophrenia (SCZ) and
tobacco smoking (cigarettes per day, CPD; Figure 2B–2C). The
stratified Q-Q plots for height, SCZ and CPD each demonstrate
the largest enrichment for tag SNPs in LD with 59UTR, and
exonic variation, showing nearly tenfold increases in terms of the
proportion of p-values expected below a given threshold under the
null hypothesis. SNPs that tag intergenic regions show nearly
tenfold depletions in comparison to all tag SNPs, although not
when compared to the expected null. SNPs tagging intronic
variation show minimal enrichment over all tag SNPs, despite
making up the largest proportion of genic SNPs (Table S3). The
pattern is consistent for all phenotypes considered (data not
shown). Given the log scale of the Q-Q plots, 90% of SNPs fall
between 0 and 1 and 99% fall between 0 and 2 on the horizontal
axis, and thus it is clear that a majority of enriched SNPs have p-
values that do not reach genome-wide significance.
We computed significance values for the curves for each
annotation category relative to those for intergenic SNPs, using a
two-sample Kolmogorov-Smirnov Test. The enrichment for
height was highly significant for all categories when compared
with the intergenic category, with all p-values less than 2.2610216.
Nearly every genic category was also significantly enriched for
each other phenotype (Table S5).
While the pattern of enrichment is consistent, the shape of the
curves varies across phenotypes. In particular, the point at which
the curves deviate from the expected null line occurs earliest for
height, followed by SCZ, and finally CPD (Figure 2A–2C),
consistent with different proportions of SNPs that are likely
associated with each trait (i.e., different levels of ‘polygenicity’).
These findings are consistent with results obtained using an
established mixture-modeling framework [17] (Text S1 and
Figures S8, S9, S10, S17, S18, S19).
Intergenic Genomic Control
The relative absence of enrichment in intergenic SNPs as we
have defined them, suggests minimal inflation due to polygenic
effects and a more robust estimate of the global null. This fact can
be exploited for better estimation of variance inflation due to
stratification [20] that is minimally confounded by true polygenic
effects [19]. We confined the estimation of the genomic inflation
factor [20], lGC, to only intergenic SNPs (Table S4) and adjusted
summary statistics for all phenotypes according to this ‘‘intergenic
inflation control’’ procedure. The stratified Q-Q plots for height
with and without intergenic inflation control are shown in Figure
S4.
Category-Specific True Discovery Rate
Since specific tag SNP categories are significantly more likely to
be associated with common phenotypes, while intergenic ones are
less likely, all tag SNPs should not be treated as exchangeable.
Variation in enrichment across diverse genic categories is expected
to be associated with corresponding variation in TDR for a given
nominal p-value threshold. A conservative estimate of the TDR
for each nominal p-value is equivalent to 12(p/q) as plotted on the
Q-Q plots (see Online Methods). This relationship is shown for
height, SCZ and CPD (Figure 2D–2E). Similar category-specific
TDR plots were calculated for each of the 14 phenotypes (data not
shown). For a given TDR the corresponding estimated nominal
p-value threshold varies with a factor of 100 from the most
enriched genic category to the intergenic category, and the pattern
is consistent across phenotypes. Since TDR is theoretically related
to predicted replication rate, it is expected that for a given p-value
threshold the replication rate will be higher for SNPs in genic
categories with high TDR. The high estimates of TDR at
significance levels below genome-wide significance is consistent
with recent work in Schizophrenia that demonstrates a high
proportion of likely true associations at reduced thresholds, but
without the needed power to reach genome-wide significance [21].
Quantification of Enrichment
While the TDR provides a quantification of enrichment for a
given nominal p-value threshold (equivalently, SNP z-score
threshold), we also provide a single number quantification of
enrichment for each LD-weighted annotation category within
each phenotype, computed as the sample mean (z2)21. The
Figure 1. Stratified Q-Q plot for height shows enrichment by
annotation categories using Linkage-Disequilibrium (LD)-
weighted scores. Genic annotation categories were: 1) 10,000 to
1,001 base pairs upstream (10 k Up); 2) 1,000 to 1 base pair upstream
(1 k Up); 3) 59 untranslated region (59UTR); 4) Exon; 5) Intron; 6) 39
untranslated region (39UTR); 7) 1 to 1,000 base pairs downstream (1 k
Down); 8) 1,001 to 10,000 base pairs downstream (10 k Down). Q-Q plot
of height with non-LD weighted category scores are shown in Figure
S3.
doi:10.1371/journal.pgen.1003449.g001
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sample mean, taken over all SNPs in a given category, provides an
estimate of the variance due to null and non-null SNPs; by
subtracting one we obtain a conservative estimate of the variance
in effect sizes attributable to non-null SNPs alone. Both TDR and
mean (z2)21 are justified based on a standard mixture model
formulation (see Text S1). These enrichment scores, normalized
by the maximum value across categories within each phenotype,
are presented in Figure 3. The 59UTR annotation category was
the most enriched category across all fourteen phenotypes (Table
S6). Additionally, the exon category is consistently more enriched
than the intron category.
Categories where each SNP tags more reference SNPs on
average or represents a larger total amount of LD could spuriously
appear enriched. We do note categorical differences in the number
of SNPs and total summed LD captured by each SNP (Tables S7
and S8) but multiple regression analyses show the effect of these
variables is negligible and independent categorical effects persist
(Table S10) despite the significant correlation among categories
(Figure S2). Likewise, systematic deviations in minor allele
frequency (MAF) across categories could bias annotation category
effects as MAF acts multiplicatively with effect size to explain
variance. We found minimal categorical stratification for MAF
that is inconsistent with this effect driving our enrichment findings
(Table S9 and Figure S6). To further address the possibility that
some of the differential enrichment of categories could be due to
category-specific genomic inflation from the above factors, we
performed null-GWAS simulations based on genotypes from the
1000 Genome Project. The results suggest that such effects are
non-existent or negligible (Table S11).
Replication Rate
To further address the possibility that the observed pattern of
differential enrichment results from spurious (i.e., non-generaliz-
able) associations due to category-specific confounding effects or
statistical modeling errors, we also studied the empirical replica-
tion rate across independent sub-studies for one phenotype (CD)
where the required sub-study summary statistics were available.
Figure 4A shows the estimated TDR curves for different
annotation categories in CD, with a similar pattern as that
described for in height, SCZ and CPD, above. TDR is an estimate
of the expected replication rate for a sufficiently large replication
sample. We hypothesized that strata with higher TDR for a given
nominal p-value would also show higher empirical replication rate.
Figure 4B shows the empirical cumulative replication rate plots as
Figure 2. Stratified Q-Q plots and true discovery rates show consistency of enrichment. Upper panel: Stratified Q-Q plots illustrating
consistent enrichment of genic annotation categories across diverse phenotypes: (A) Height, (B) Schizophrenia (SCZ), and (C) Cigarettes per Day
(CPD). All figures are corrected for inflation using intergenic inflation control. Only nominal p-values below the standard genome-wide significance
threshold (p,561028) are shown. Lower panel: Stratified True Discovery Rate (TDR) plots illustrating the increase in TDR associated with increased
enrichment in (D) Height, (E) SCZ and (F) CPD. Genic annotation categories were: 59 untranslated region (59UTR), Exon, Intron, 39 untranslated region
(39UTR), All SNPs, in addition to Intergenic.
doi:10.1371/journal.pgen.1003449.g002
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a function of nominal p-value for the same categories as for the
stratified TDR plot in Figure 4A. Consistent with the category-
specific TDR pattern, we found that the nominal p-value
corresponding to a wide range of replication rates was 100 times
higher for intergenic relative to the most enriched genic category
(59UTR). Similarly, SNPs from genic annotation categories
showing the greatest enrichments replicated at higher rates, up
to five times higher than intergenic for 59UTR SNPs, independent
of p-value thresholds. The increase in replication rate was found to
be greatest for SNPs that do not meet genome-wide significance,
suggesting that adjusting p-value thresholds according to the
estimated category-specific TDR could greatly improve the
discovery of replicating SNP associations.
Increased Power Using Stratified False Discovery Rate
In order to demonstrate the utility of the enriched category
information for improved discovery, we leveraged an established
method for computing stratified False Discovery Rates [9]. The
sFDR method improves the power of traditional methods for FDR
control [22] by taking advantage of pre-defined, differentially
enriched strata among multiple hypothesis testing p-values. Here,
we define an increase in power from using stratified (vs.
unstratified) methods as a decreased Non-Discovery Rate (NDR)
for a given level of FDR control a, where NDR is the proportion
of false negatives among all non-null tests [23]. Specifically, the
ratio of 1-NDR from stratified FDR control to 1-NDR from
unstratified FDR control captures the relative power of the two
approaches. This ratio can be shown to be equivalent to the ratio
of the number of SNPs rejected by sFDR to the number rejected
by unstratified FDR for a common level a.
For each phenotype we divided the SNPs into independent
strata according to its predicted tagged variance (z2). Tagged
variance was predicted using on a linear model with regression
weights for each annotation category trained using the height
GWAS summary statistics. The enrichment of these strata is
presented in Figure S11. In Figure 5 (and Table S12) we show an
increase in the number of discovered SNPs. For example, for
a= .05 the increased proportion of declared non-null SNPs using
sFDR ranges from 20% in height to 300% in schizophrenia.
Leveraging our genic annotation categories in the sFDR
framework provides one possible avenue for improving the output
of likely non-null SNPs in GWAS by taking advantage of the non-
exchangeability of SNPs demonstrated by our enrichment
analyses. Other formulations of strata and continued investigations
Figure 4. Independent study replication confirms enrichment
in Crohn’s disease. (A). Stratified True Discovery Rate (TDR) plots
illustrating the increase in TDR associated with increased enrichment.
(B) Cumulative replication plot showing the average rate of replication
(p,.05) within sub-studies for a given p-value threshold shows
enriched categories replicate at a higher rate in independent samples.
The vertical intercept is the overall replication rate per category.
doi:10.1371/journal.pgen.1003449.g004
Figure 3. Categorical enrichment for seven diverse phenotypes. The relative pattern of enrichment, as measured by the mean (z-score221)
after intergenic inflation control, of LD-weighted genic annotation categories remain consistent. Results for all phenotypes are shown in Figure S5,
Table S6.
doi:10.1371/journal.pgen.1003449.g003
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into enrichment are likely to further improve the power of this
approach.
Discussion
Our results show a significant and consistent pattern of
enrichment among genic elements, particularly the 59UTR, exon
and 39UTR categories, for association with diverse complex traits
and disorders. Intergenic SNPs were depleted more than tenfold.
This has important analytical and conceptual implications. The
results suggest that all tag SNPs should not be treated as
exchangeable, but rather functional annotations of the underlying
tagged SNPs can be leveraged in SNP discovery. Moreover, the
results point to a common functional nature of the polygenetic
architecture across diverse complex phenotypes.
GWAS have traditionally treated all SNPs as exchangeable,
implicitly assigning all SNPs equal a priori probability of
association. The current findings suggest that this assumption of
exchangeability is not valid, and that the traditional statistical
approaches to GWAS are highly suboptimal. Sun et al [13] have
laid the groundwork for incorporating this non-exchangeability
into Hypothesis Driven Genome-Wide Association Studies (HD-
GWAS), and further applications and development of such
methods is likely to prove fruitful. To illustrate the utility of these
approaches we used our LD-weighted tag SNP annotations,
combined with an established method for computing stratified
False Discovery Rates, to demonstrate improved discovery of
SNPs in GWAS under this testing framework. Annotation
categories were chosen based on previous literature suggesting
that SNPs in and near genes are likely to harbor many true
polygenic effects. We provide a proof of principle, using intuitive
categories, that a priori information about SNPs, irrespective of
phenotype, can improve discovery of likely non-null SNPs. Given
the wealth of information available for SNP variants, it is likely
that other annotation schemes will potentially yield even greater
enrichment and further increase the gains of our basic approach.
We expect this approach will be of particular importance in
polygenic complex phenotypes. Only a small fraction of the
heritability is explained by currently discovered variants but
converging evidence suggests much more remains buried in
GWAS (i.e., traits with a large ‘‘missing heritability’’) [4] for these
traits.
Moreover, the non-exchangeability of SNPs based on LD-
weighted genic categories has important implications for the
generalizability of estimated SNP effect sizes. In particular, SNPs
in highly enriched categories will have effect size estimates that
replicate strongly in independent samples, whereas SNPs in
impoverished categories will have effect sizes that replicate weakly
in independent samples [17] (Figure S10). Identifying SNPs with
generalizable effects is crucial to improving the predictive power of
polygenic risk scores that combine SNP effects to predict variation
in complex traits and diseases in new samples [24]. Properly
assessing the generalization performance of SNP effect sizes will be
of high importance for personalized medicine based on polygenic
risk scores.
While knowing which SNP categories are enriched for true
associations can guide gene discovery, knowing which SNPs are
unlikely to have an effect is also important and can guide control
of spurious inflation through improved genomic inflation correc-
tion [19,20]. We show how the genic enrichment pattern can be
used for genomic inflation control in GWAS. By estimating
genomic control from intergenic tag SNPs, we can minimize the
contamination of inflation estimates from true polygenic associa-
tions. While emerging studies have suggested that polygenic effects
are detectable in GWAS data [5,6], particularly in and around
genes [6,16], and the presence of these effects is consistent with a
skewed distribution of p-values [17,25] that resembles spurious
inflation [19], differential confounds among our categories could
persist. We provided a null GWAS (Table S11) and found no
indications of spurious enrichment due to differential MAF and
LD structure among our categories. Further, if our findings were
due to spurious category-specific inflation, including differential
population stratification, one would not expect a mirroring
increase in replication across independent samples (Figure 4),
except under the extreme condition where the population
structure of the discovery sample was mirrored in the replication
sample. In addition, the variable shape of the enrichment,
deviating at different points along the expected line for different
phenotypes, is inconsistent with spurious variance inflation. It is
also of importance to note that the presence of spurious category-
specific inflation would imply that any GWAS association within
an enriched category (i.e., tagging an exonic or UTR SNP) should
be considered less reliable. Our findings are consistent with the
presence of true polygenic effects, however, we cannot entirely rule
out contributions of potential confounding effects or alternate
hypotheses. It is highly implausible, however, that they would
explain away both the described enrichment and increased
replication.
Conceptually, our results support findings that aspects of the
genetic architecture are consistent across phenotypes [26], and
previous suggestions from both model organisms [27] and humans
[6,16] that polygenic contributions are greater from variants in
and around genes. Our findings agree with emerging trends in
Figure 5. Enrichment improves discovery using established methods. Among three phenotypes, (A) Height, (B) Crohn’s Disease, (C) and
Schizophrenia, we demonstrate an increased discovery of SNPs at a given FDR when incorporating the enriched genic annotation information into an
established stratified false discovery rate (sFDR; red) framework. SNPs declared significant by sFDR also replicate at a higher rate (Figure S12).
doi:10.1371/journal.pgen.1003449.g005
Differential Enrichment among SNP Categories
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model organisms [26] and post-hoc GWAS analyses [28–30]
suggesting that quantitative traits are affected by a large but
quantifiable number of polymorphisms, inconsistent with ‘infini-
tesimal’ models [31], but notably polygenic. We also show
evidence that tagged variance is proportional to genotypic
variance (Figures S6 and S7), which supports the notion that
common variation explains an important part of the variability in
common diseases and traits [32].
Our findings also suggest that regulatory genic elements may
be particularly enriched for polygenic effects. This is in line with
the most strongly associated SNPs from GWAS, which mainly tag
regulatory genic elements [3]. The 59UTR, specifically, is
important for the regulation of gene expression [33] making it
a compelling candidate for playing a causal role in complex trait
variation [1]. Also, 59UTRs are less conserved evolutionarily than
coding regions [34], despite their noted functionality, pointing to
a potential source for regulatory variation thought to drive
evolutionary differences among primates [35] and other species.
We also found a stronger enrichment of SNPs tagging exons
compared to introns. However, because we are considering tag
SNPs we can only speculate about the functional consequences of
the underlying causal variants.
Exome sequencing studies have identified causal variants for
Mendelian disorders by leveraging hypotheses about the genetic
architecture of these traits and thus focusing on protein changing
variants [36]. While methods are continually improving for
predicting the functional consequences of coding changes, predicting
regulatory function has remained a challenge. Future target capture
methods, deep sequencing efforts and custom SNP array designs, as
well as functional prediction efforts in complex traits may improve
power and utility by adding focus to regulatory elements, in
particular 59UTRs. As other potential annotation categories, such as
transcription factor binding sites, methylation targets, conservation/
selection, and gene expression patterns, become better characterized
the current analyses could be extended to include these.
Materials and Methods
Genome-Wide Association Study (GWAS) Data
Fourteen phenotypes, body mass index (BMI) [37], height, waist
to hip ratio [38] (WHR), Crohn’s disease [39] (CD), ulcerative colitis
[40] (UC), schizophrenia [41] (SCZ), bipolar disorder [42] (BD),
smoking behavior as measured by cigarettes per day [43] (CPD),
systolic and diastolic blood pressure [44] (SBP, DBP), and plasma
lipids [45] (triglycerides, TG, total cholesterol, TC, high density
lipoprotein, HDL, low density lipoprotein, LDL), were considered.
Genome-wide association study (GWAS) results were obtained as
summary statistics (p-values or z-scores) from public access websites
(BMI, Height, WHR, TC, TG, HDL, LDL), published supple-
mentary material (SBP, DBP), or through collaborations with
investigators (CD, UC, SCZ, BD). For CD, pre-meta-analysis, sub-
study specific p-values and effect sizes (z-scores) were obtained from
the study principal investigators. In total these studies considered
more than 1.3 million phenotypic observations, but considerable
sample overlap makes the number of unique individuals much less.
For details, see Text S1 and Table S1.
GWAS Summary Statistics Processing
The summary statistics from the respective GWAS meta-
analyses, derived according to best practices, were used as-is. No
further processing was performed, with the exception of intergenic
inflation control (described below). Results from SNPs with
reference SNP (rs) numbers that did not map to our 1000
genomes project (1KGP) reference panel were excluded.
Positional Annotation Categories
Bi-allelic SNP genotypes from the European reference sample
provided by the November 2010 release of Phase 1 of the 1KGP
were obtained in pre-processed form from http://www.sph.umich.
edu/csg/abecasis/MACH/download/. Using Plink version 1.07
[46,47] 1KGP SNPs with a minor allele frequency less than 1%,
missing in more than 5% of individuals and/or violating Hardy-
Weinberg equilibrium (p,161026) were excluded from the
reference panel. Individuals missing more than 10% of genotypes
were excluded.
Each remaining 1KGP SNP was assigned a single, mutually
exclusive genic annotation category based on its genomic
position (hg19). Genic annotation categories were: 1) 10,000 to
1,001 base pairs upstream (10 k Up); 2) 1,000 to 1 base pair
upstream (1 k Up); 3) 59 untranslated region (59UTR); 4) exon; 5)
intron; 6) 39 untranslated region (39UTR); 7) 1 to 1,000 base
pairs downstream (1 k Down); 8) 1,001 to 10,000 base pairs
downstream (10 k Down), all with reference to protein coding
genes only. Annotations were assigned based on the first gene
transcript listed in the UCSC known genes database [48]. In
total 9,078,405 1KGP SNPs were assigned positional categories.
All positional categories were scored 0 or 1. For further details
see Text S1.
Linkage Disequilibrium (LD)-Weighted Scoring
For each GWAS tag SNP a pairwise correlation coefficient
approximation to LD (r2) was calculated for all 1KGP SNPs
within 1,000,000 base pairs (1 Mb) of the tag SNP using Plink
version 1.07 [46,47]. LD scores were thresholded providing
continuous valued estimates from 0.2 to 1.0; r2 values ,0.2 were
set to 0 and each SNP was assigned an r2 value of 1.0 with itself.
LD-weighted annotation scores were computed as the sum of r2
LD between the tag SNP and all 1KGP SNPs positioned in a
particular category. Each tag SNP was assigned to every LD-
weighted annotation category for which its annotation score
was greater than or equal to 1.0. The resulting LD-weighted
annotation categories were not mutually exclusive such that each
GWAS tag SNP could be annotated with multiple categories.
Summary statistics describing the distribution of scores in each
category for the 2,558,411 SNPs, representing the union of all
GWAS considered, are provided in Tables S2 and S3. Figure S1
provides a schematic of our scoring algorithm. All analyses were
repeated using a second set of LD thresholding parameters and
found to be robust (Text S1 and Figures S13, S14, S15, S16).
Intergenic SNPs
Intergenic SNPs were determined after LD-weighted scoring
and defined as having LD-weighted annotations scores for each
of the eight categories equal to zero. In addition they were
defined to not be in LD with any SNPs in the 1KGP reference
panel located within 100,000 base pairs of a protein coding gene,
within a noncoding RNA, within a transcription factor binding
site nor within a microRNA binding site. SNPs labeled intergenic
were defined to be a specific collection of non-genic SNPs chosen
to not represent any functional elements within the genome
(including through LD). Because of how they are defined these
SNPs are hypothesized to represent a collection of null
associations. Other non-genic categories (1 k up, 10 k up, 1 k
down and 10 k down) were included in our analyses to ensure
SNPs not too far away from genes, but not within protein coding
genes, were represented by non-genic categories and enrichment
due to these SNPs was not solely attributed to LD with genic
categories.
Differential Enrichment among SNP Categories
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Stratified Q-Q Plots and Enrichment
Q-Q plots compare two probability distributions. For each
phenotype, for all SNPs and for each categorical subset, 2log10
nominal p-values were plotted against 2log10 empirical p-values.
Leftward deflections of the observed distribution from the
projected null line reflect increased tail probabilities in the
distribution of test statistics (z-scores) and consequently an over-
abundance of low p-values compared to that expected by chance.
We qualitatively refer to this deflection as ‘‘enrichment’’ (Figure 1
and Figure 2, Figure S3).
We estimated the significance of the annotation enrichment
using two sample Kolmogorov-Smirnov (KS) Tests to compare the
distribution of test statistics in each genic annotation category to
the distribution of the intergenic category, for each phenotype.
SNPs were pruned randomly to approximate independence
(r2,0.2) ten times and Table S5 reports the p-value corresponding
to the median KS statistics from the ten comparisons.
Intergenic Inflation Control
The empirical null distribution in GWAS is affected by global
variance inflation due to factors including population stratification
and cryptic relatedness [20] and deflation due to over-correction
of test statistics for polygenic traits by standard genomic control
methods [19]. We applied a control method leveraging only
intergenic SNPs that are likely depleted for true associations. All p-
values were converted into z-scores and, for each phenotype, the
genomic inflation factor [20], lGC, was estimated for intergenic
SNPs. All test statistics were divided by l GC.
The inflation factor lGC was computed as the median z-score
squared divided by the expected median of a chi-square
distribution with one degree of freedom or all phenotypes except
CPD, where the .95 quantile was used in place of the median. For
correction statistics see Table S4.
Quantification of Categorical Enrichment
For each phenotype, enrichment was measured as the mean(z-
score221) for each category and normalized by the largest value
per phenotype. The mean(z-score221) is a conservative estimate of
the variance attributable to non-null SNPs, given a standard
normal null distribution and a non-null distribution symmetric
around zero (see Text S1).
Q-Q Plots and False Discovery Rate (FDR)
Enrichment seen in the conditional Q-Q plots can be directly
interpreted in terms of the FDR. Specifically, for a given p-value
cutoff, the Bayes FDR [17] is defined as
FDR pð Þ~p0F0 pð Þ=F pð Þ, ð1Þ
where p0 is the proportion of null SNPs, F0 is the null cdf, and F is
the cdf of all SNPs, both null and non-null. Under the null
hypothesis, F0 is the cdf of the uniform distribution on the unit
interval [0,1], so that Eq. [1] reduces to
FDR pð Þ~p0p=F pð Þ: ð2Þ
The cdf F can be estimated by the empirical cdf q =Np/N/cdf F p
is the number of SNPs with p-values less than or equal to p, and N
is the total number of SNPs. Replacing F by q and replacing p0
with unity in Eq. [2], we get
FDR pð Þ&p=q, ð3Þ
This is upwardly biased, and hence p/q is conservative estimate of
the FDR, and 12p/q is a conservative estimate of the Bayes TDR
[17]. If p0 is close to one, as is likely true for most GWAS, the
increase in bias from setting p0 to one in Eq. [3] is minimal.
Referring to the formulation of the Q-Q plots, we see that FDR(p)
is equivalent to the nominal p-value under the null hypothesis
divided by the empirical quantile of the p-values. Given the2log10
transformation applied to the Q-Q plots, we can easily read off
{log10 FDR pð Þð Þ&log10 qð Þ{log10 pð Þ ð4Þ
demonstrating that the (conservatively) estimated FDR is directly
related to the horizontal shift of the curves in the stratified Q-Q
plots from the expected line x= y, with a larger shift corresponding
to a smaller FDR. For the TDR plots in Figure 2, we estimated the
TDR for each genic category according to Eq. [4].
Eq. [3] is the Empirical Bayes point estimate of the Bayes FDR
given in Efron (2010). Using Eq. [3] to control FDR (i.e., the
expected proportion of falsely rejected null hypotheses) [22] is
closely related to the ‘‘fixed rejection region’’ approach of Storey
[49,50]. Specifically, Storey [49] showed, for a given FDR a,
rejecting all null hypotheses such that p/q,a is equivalent to the
Benjamini-Hochberg procedure and provides asymptotic control
of the FDR to a if the true null p-values are independent and
uniformly distributed. Storey [49] also noted that asymptotic
control is preserved under positive blockwise dependence, whereas
Schwartzman and Lin [51] showed that Eq. [3] is a consistent
estimator of FDR for asymptotically sparse dependence (i.e. the
proportion of correlated pairs of p-values goes to zero as the
number of hypothesis tests becomes large). Sparse dependence is a
good description of the dependence present in GWAS data; for
example, based on a threshold of r2..05 within 1,000,000
basepairs, we estimate the ratio of correlated pairs (r2..05) to
total pairs of p-values at 0.000128.
Replication Rate
For each of eight sub-studies contributing to the final meta-
analysis in the CD report we independently adjusted z-scores using
intergenic inflation control. For each of 70 (8 choose 4) possible
combinations of four-study discovery and four-study replication
sets, we calculated the four-study combined discovery z-score and
four-study combined replication z-score for each SNP as the
average z-score across the four studies, multiplied by two (the
square root of the number of studies). For discovery samples the z-
scores were converted to two-tailed p-values, while replication
samples were converted to one-tailed p-values preserving the
direction of effect in the discovery sample. For each of the 70
discovery-replication pairs cumulative rates of replication were
calculated over 1000 equally-spaced bins spanning the range of
negative log10(p-values) observed in the discovery samples. The
cumulative replication rate for any bin was calculated as the
proportion of SNPs with a 2log10(discovery p-value) greater than
the lower bound of the bin with a replication p-value,.05.
Cumulative replication rates were calculated independently for
each of the eight genic annotation categories as well as intergenic
SNPs and all SNPs. For each category, the cumulative replication
rate for each bin was averaged across the 70 discovery-replication
pairs and the results are reported in Figure 4. The vertical
intercept is the overall replication rate.
Stratified False Discovery Rates
A multiple linear regression was used to predict the tagged
variance (z2) for each SNP in the height GWAS from the
Differential Enrichment among SNP Categories
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unthresholded LD-weighted annotation scores. Using the category
weights determined from this ‘training’ regression on the height
GWAS, the tagged variance for each SNP was predicted from its
annotation vector for each other phenotype. For each phenotype,
SNPs were grouped into strata according to the rank of this
predicted tagged variance. Enrichment for each stratum was
demonstrated using Q-Q plots as described above (Figure S11).
We note that for Figure 5A the height data serves as both our ‘test’
(for creating strata) and ‘training’ (for detecting enrichment) data,
but for each other GWAS the training and test data is
independent. Sun et al [9] described a stratified False Discovery
Rate (sFDR) procedure which can result in improved statistical
power over traditional FDR methods [22] when a collection of
statistical tests can be grouped into disjoint strata with different
levels of enrichment. In order to demonstrate the utility of using
genic annotation categories in combination with sFDR for
increasing power, we computed the number of SNPs deemed
significant at a given FDR threshold using both traditional [22]
and stratified FDR, where the strata were determined by the
predicted tagged variance for each SNP based on regression
weights determined from the height GWAS summary statistics
(Figure 5). The increase in rejections for a common threshold a
when using sFDR is equivalent to increased power demonstrated
by a ratio of one minus Non-Discovery Rates (1-NDRs) for sFDR
to FDR greater than 1 [23].
We also computed the average proportion of SNPs above a
given rank (i.e. top 1000) that replicated based on unadjusted and
strata adjusted ranks (determined from the sFDR procedure)
across the 70 permutations of four study discovery and four study
replication samples possible in the eight study CD meta-analysis
GWAS (Figure S12). These results demonstrate that for a given
threshold, SNPs ranked via genic category-informed sFDR
replicate in higher numbers than SNPs ranked via traditional
FDR.
Supporting Information
Figure S1 Annotation Category Scoring Schematic. For each
GWAS tag SNP in the 1KGP we estimated r2 LD with all SNPs
within 1 megabase. LD scores were thresholded at r2.0.2. For
each SNP the sum of LD with each genic annotation category was
recorded. SNPs were assigned to categories by thresholding
continuous scores with an inclusive lower bound of 1.0. Positional
(non LD-weighted) scores were recorded as the annotation for the
GWAS tag SNP’s location only.
(TIF)
Figure S2 Correlations among annotation categories and scores.
(A) Heat map displaying the Spearman’s correlation coefficients
among continuous valued LD-weighted annotation scores. (B)
Heat map displaying the Spearman’s correlation coefficients
among thresholded and binarized annotation categories presented
in Q-Q plots. Correlations are reported using the annotations for
the union of SNPs across all GWAS (2,558,411 SNPs).
(TIF)
Figure S3 Enrichment in Height without LD weighted annota-
tion. Q-Q plot showing enrichment of genic annotation categories
using positional scores (non LD-weighted). Enrichment patterns
are present, but less apparent than using LD-weighted annotation
scores (Figure 1). No inflation correction was performed by our
group.
(TIF)
Figure S4 Height before and after Intergenic Inflation Control.
(A) Q-Q plot of height without correction for genomic inflation. (B)
Q-Q plot of height after correction for genomic inflation using the
‘intergenic inflation control’. Note the overcorrection (grey line
below null-hypothesis line, marked by red arrows) in the un-
corrected Q-Q plot in Panel A is resolved in Panel B. Although
slight, because of the log scaling of these plots, this slight deflation
(left of 1.5 on the x-axis of Panel A) occurs over a much greater
proportion of the distribution and thus has a stronger effect on the
mean and median of the distribution than the more visually
apparent inflation in the extreme tails (right of 2 on the x-axis of
Panel A). For lambda values, see Table S4. Only nominal p-values
below the standard genome-wide significance threshold
(p,561028) are shown.
(TIF)
Figure S5 Categorical enrichment for all phenotypes. The
mean(z-score221) for each category of SNPs per phenotype
reveals consistent enrichment across fourteen phenotypes. BD,
Bipolar Disorder; BMI, Body Mass Index; CD, Crohn’s disease;
CPD, Cigarettes per Day; DBP, Diastolic blood pressure; HDL,
High density lipoprotein; LDL, Low density lipoprotein; SBP,
systolic blood pressure; SCZ, Schizophrenia; TC, total Cholester-
ol; TG, triglycerides; UC, Ulcerative Colitis; WHR, Waist-hip-
ratio.
(TIF)
Figure S6 Mean Z2 per decile of genetic variance by category.
The figure shows the relationship between genetic variance
defined as a function of minor allele frequnecy (MAF) by
MAF6(1-MAF) and effect size (mean z-score2) per genic
annotation category for height. The mean is taken at each decile
of genetic variance. The red lines are fits from generalized additive
models to the mean mean observed squared z-scores. Note the
clear increase in effect size with increasing MAF, which shows
similar effect of MAF across categories. The exception is for the
intergenic category which shows little multiplicative effect further
suggesting it harbors a majority of true null SNPs.
(TIF)
Figure S7 Enrichment by MAF category for height and
schizophrenia. The effect of minor allele frequency (MAF) is not
consistent across phenotypes. (A) For height more common SNPs
show a continually larger enrichment than less common SNPs. (B)
For Schizophrenia common SNPs show more enrichment at
moderate to small z-scores, but for larger z-scores less common
SNPs are more enriched.
(TIF)
Figure S8 locfdr plot for all SNPs in Crohn’s disease. Mixture
model fits for all SNPs for Crohn’s disease. Black: empirical z-score
distribution, Purple: estimated non-null distribution, Green line:
smooth estimate of mixture distribution (full distribution), Blue
line: smooth estimate of the null distribution. Diamonds: local false
discovery rate (LFDR) of 0.2. The estimated proportion of non-
null SNPs varies by category, as does the variance in the estimated
non-null effect size.
(TIF)
Figure S9 locfdr plots for genic annotation categories in Crohn’s
disease. Mixture model fits for each annotation category for
Crohn’s disease. Black: empirical z-score distribution, Purple:
estimated non-null distribution, Green line: smooth estimate of
mixture distribution (full distribution), Blue line: smooth estimate
of the null distribution. Diamonds: local false discovery rate
(LFDR) of 0.2. The estimated proportion of non-null SNPs varies
by category, as does the variance in the estimated non-null effect
size.
(TIF)
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Figure S10 Z-score–z-score plots confirm mixture model
predictions. (A) Expected a posteriori estimates of effect size for a
given observed z-score. (B) Z-score-z-score plot demonstrates the
empirical replication z-scores closely match the expected a posteriori
effect sizes and are strongly dependent upon genic annotation
category.
(TIF)
Figure S11 Regression based strata enrichment. Q-Q plot
enrichment for the regression based strata for (A) Height, (B)
Crohn’s Disease (CD), and (C) Schizophrenia (SCZ). SNPs
predicted to have a higher tagged variance (z2) show greater
levels of enrichment. Enrichment is consistent across these three
phenotypes, despite being determined from a regression model
only using the summary statistics from the height GWAS.
(TIF)
Figure S12 Replication Rates of sFDR versus FDR. For a given
SNP rank threshold (i.e., top 500 SNPs), those ranked by the genic
annotation category-informed stratified FDR show a greater
absolute number of replications, and thus a greater rate of
replication, when compared to the annotation un-informed
standard FDR. When incorporated into an FDR framework, the
enriched genic annotation categories lead to an increased rate of
true discovery among SNPs at a given cut off.
(TIF)
Figure S13 Stratified QQ-plots with different scoring parame-
ters. The original stratified QQ-plots for height (A), Schizophrenia
(B), and Cigarettes per day (C) using LD-weighted annotation
categories created from an LD matrix describing the pairwise
correlation between each GWAS SNP and all 1000 genomes SNPs
(described above) including r2 values greater than 0.2 and within 1
megabase of the target GWAS SNP show a qualitatively similar
pattern of enrichment when the scoring parameters are changed to
include all pairwise r2 values greater than 0.05 and within 2
megabases (Height, D; Schizophrenia, E; Cigarettes per day, F).
(TIF)
Figure S14 Mean(z-score221) plot with alternate scoring
parameters. The patterns among the mean(z-score221) for each
category of SNPs per phenotype is robust to LD-weighted
annotation scoring parameters as the patterns match those shown
in Figure S6. Here we show results when pairwise LD is
thresholded at r2.0.05 and within 2 megabases (original scoring:
r2.0.2 and within 1 megabase). BD, Bipolar Disorder; BMI, Body
Mass Index; CD, Crohn’s disease; CPD, Cigarettes per Day; DBP,
Diastolic blood pressure; HDL, High density lipoprotein; LDL,
Low density lipoprotein; SBP, systolic blood pressure; SCZ,
Schizophrenia; TC, total Cholesterol; TG, triglycerides; UC,
Ulcerative Colitis; WHR, Waist-hip-ratio.
(TIF)
Figure S15 Replication rate among categories with alternate
scoring parameters. A regenerated cumulative replication plot
(Figure 4B) showing the average rate of replication (p,.05) within
independent sub-studies for a given p-value. The enrichment
produced by the alternate LD weighted annotation scoring
parameters (including r2.0.05 and all SNPs within 2 megabases)
results in a similar pattern of increased replication as with the
original parameters (including r2.0.2 and all SNPs within 1
megabases), with the exception of the intergenic category, which
shows a noticeable decrease in the replication rate.
(TIF)
Figure S16 Relationship between total categorical total LD and
z-score2. The mean (z2) of each category, using the height GWAS,
as we change the threshold for inclusion for both the original (A;
including r2.0.2 and within 1 megabases), and alternate (B;
r2.0.05 and within 2 megabases) parameters for LD weighted
scoring. The mean(z2) increases approximately monotonically
each category, but with noticeably different slopes. The 59UTR
category in figure A becomes unstable at high thresholds because
there are very few SNPs remaining. Changing to a more inclusive
LD weighted scoring increases the number of SNPs with high
scores and improves the relationship. This suggests that even
greater enrichment could be achieved by tuning the categorical
inclusion threshold upwards.
(TIF)
Figure S17 Parametric mixture model fits to Q-Q plots. Q-Q Plot
for Height (A) and Crohn’s Disease (B). Solid black lines are actual
data. Dotted black lines are Q-Q curves under the global null
hypothesis. Solid red lines are fitted Q-Q curves fromWeibull mixture
model for transformed p-values. Note, upper limit in Q-Q plot y-axes
is 7.3, corresponding to GWAS-significance threshold of p=561028.
(TIF)
Figure S18 Effect of non-null proportion on Q-Q plots.
Predicted Q-Q Plot for Crohn’s Disease (CD; solid black line)
from parametric Weibull mixture model fit (model given by
Equation [S9]). The blue line is the predicted Q-Q curve of the
CD data if the non-null proportion p1 were 0.001 instead of the
value 0.026 estimated from the CD data. The red line is the
predicted Q-Q curve if the non-null proportion p1 were 0.10.
(TIF)
Figure S19 Effect of sample size on Q-Q plots. Predicted Q-Q
Plot for Crohn’s Disease (CD; solid black line) from parametric
Weibull mixture model fit (model given by Equation [S9]). The
blue line is the predicted Q-Q curve of the CD data if the sample
size were half as large as the true sample size (n = 51,109). The red
line is the predicted Q-Q curve of the CD data if the sample size
were five times as large as the true sample size.
(TIF)
Table S1 Descriptive statistics for each GWAS study. All traits
are highly heritable and summary statistics are from well-powered
studies. All Studies were imputed with using the HapMap phase II
as a reference, with the exception of CD, UC and SCZ that used
HapMap phase III as a reference. These statistics describe the
results of the study in the form they were obtained by our group.
(XLSX)
Table S2 LD-weighted score distribution for the union of SNPs
across all studies. The average score for different categories varies
widely and reflects the relative abundance of the different elements
within the genome. *Note intergenic scores are binary, with a
score of 1 denoting an intergenic SNP.
(XLSX)
Table S3 The number of SNPs per annotation category. The
table shows the number of tag SNPs in each annotation category
from each GWAS without LD based annotation (using only
positional information (No LD) and after LD based annotation
(LD). Note the increased number of SNPs in all annotation
categories, especially in annotation categories such as 39UTR and
59UTR when using LD-weighted categories. BD, Bipolar
Disorder; BMI, Body Mass Index; CD, Crohn’s disease; CPD,
Cigarettes per Day; DBP, Diastolic blood pressure; HDL, High
density lipoprotein; LDL, Low density lipoprotein; SBP, systolic
blood pressure; SCZ, Schizophrenia; TC, total Cholesterol; TG,
triglycerides; UC, Ulcerative Colitis; WHR, Waist-hip-ratio.
(XLSX)
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Table S4 Estimated genomic inflation factors before and after
intergenic inflation control (IIC). We present the estimates from
either all SNPs or intergenic SNPs. The lGC values calculated
before IIC were calculated from the summary statistics as they
were made available to us, either by collaborators or public data
repositories. Many of these studies already had performed a
standard genomic control procedure, adjusting the test statistics
down, to correct for inflation. For these studies our procedure may
correct statistics upwards, increasing the computed lGC values.
We leveraged the intergenic SNPs to estimate inflation because
their relative depletion of associations suggests they provide a
robust estimate of true null SNPs that is less contaminated by
polygenic effects. Using annotation categories in this fashion is
important given concerns posed by recent GWAS [8] about the
over-correction of test statistics using standard genomic control
[15]. Values greater than 1 indicate inflation and values less than 1
indicate an over correction, relative to the theoretical empirical
null distribution. lGC was calculated as the ratio of the median z-
score2 to the expected median of a Chi-square distribution with 1
degree of freedom, for all SNPs and intergenic SNPs indepen-
dently. IIC, Intergenic Inflation Control; BD, Bipolar Disorder;
BMI, Body Mass Index; CD, Crohn’s disease; CPD, Cigarettes per
Day; DBP, Diastolic blood pressure; HDL, High density
lipoprotein; LDL, Low density lipoprotein; SBP, systolic blood
pressure; SCZ, Schizophrenia; TC, total Cholesterol; TG,
triglycerides; UC, Ulcerative Colitis; WHR, Waist-hip-ratio.
(XLSX)
Table S5 Significance of QQ-plot enrichment. The p-values of
the enrichment of the Q-Q plots for all phenotypes compare
intergenic annotation category with each other annotation
category. Each p-value corresponds to the median Kolmogorov-
Smirnov (KS) statistic from 10 iterations of each comparison for 10
different random prunings of SNPs to approximate independence
(r2,0.2). We note that the KS test used is known to be overly
conservative when distributions differ only in the extreme tails.
The results from all categories for CPD, although consistent in
direction with each other phenotype, do not reach significance
likely because the differences are most strongly confined to the
extreme tails. BD, Bipolar Disorder; BMI, Body Mass Index; CD,
Crohn’s disease; CPD, Cigarettes per Day; DBP, Diastolic blood
pressure; HDL, High density lipoprotein; LDL, Low density
lipoprotein; SBP, systolic blood pressure; SCZ, Schizophrenia;
TC, total Cholesterol; TG, triglycerides; UC, Ulcerative Colitis;
WHR, Waist-hip-ratio.
(XLSX)
Table S6 Enrichment Scores. Here we present in a table the
enrichment values used to create Figure 2 and Figure S6, the
normalize mean(z-score2–1). All values are expressed in relative
proportions of the highest category for each phenotype. BD,
Bipolar Disorder; BMI, Body Mass Index; CD, Crohn’s disease;
CPD, Cigarettes per Day; DBP, Diastolic blood pressure; HDL,
High density lipoprotein; LDL, Low density lipoprotein; SBP,
systolic blood pressure; SCZ, Schizophrenia; TC, total Cholester-
ol; TG, triglycerides; UC, Ulcerative Colitis; WHR, Waist-hip-
ratio.
(XLSX)
Table S7 Per category average per SNP total tagged LD. The
average total LD score for GWAS tag SNPs per LD-weighted
genic annotation category for each phenotype is shown. Total LD
is measured as the sum of pairwise LD scores (r2..2) relating each
GWAS tag SNP to all 1KGP SNPs within 1,000,000 base pairs.
Note the consistent pattern across phenotypes, with large variation
between annotaion categories, with highest LD score in 59UTR.
BD, Bipolar Disorder; BMI, Body Mass Index; CD, Crohn’s
disease; CPD, Cigarettes per Day; DBP, Diastolic blood pressure;
HDL, High density lipoprotein; LDL, Low density lipoprotein;
SBP, systolic blood pressure; SCZ, Schizophrenia; TC, total
Cholesterol; TG, triglycerides; UC, Ulcerative Colitis; WHR,
Waist-hip-ratio.
(XLSX)
Table S8 Per category average per SNP number of tagged
SNPs. The average total number of SNP tagged (r2.0.2) by a tag
SNP per genic annotation category for each phenotype is shown.
Note the consistent pattern across phenotypes, with variation
between categories, and highest number in 59UTR. The
distribution of block sizes does match the ordering of enrichment
by category. BD, Bipolar Disorder; BMI, Body Mass Index; CD,
Crohn’s disease; CPD, Cigarettes per Day; DBP, Diastolic blood
pressure; HDL, High density lipoprotein; LDL, Low density
lipoprotein; SBP, systolic blood pressure; SCZ, Schizophrenia;
TC, total Cholesterol; TG, triglycerides; UC, Ulcerative Colitis;
WHR, Waist-hip-ratio.
(XLSX)
Table S9 Per category average MAF. The average minor allele
frequency of GWAS tag SNPs in each genic annotation category
for every phenotype is not consistent with this effect driving our
enrichment patterns. Note the similarities across phenotypes and
annotation categories. BD, Bipolar Disorder; BMI, Body Mass
Index; CD, Crohn’s disease; CPD, Cigarettes per Day; DBP,
Diastolic blood pressure; HDL, High density lipoprotein; LDL,
Low density lipoprotein; SBP, systolic blood pressure; SCZ,
Schizophrenia; TC, total Cholesterol; TG, triglycerides; UC,
Ulcerative Colitis; WHR, Waist-hip-ratio.
(XLSX)
Table S10 Multiple regression analysis predicting log(Z2) in
height. A multiple regression analysis reveals a minimal, but
significant, effect of total LD on the log z2 for height. This
represents a minimal, but significant, effect of overall LD block
size on enrichment. Categorical effects remain independently
strong in this analysis with an effect size order that mirrors
enrichment.
(DOCX)
Table S11 Null GWAS Simulations. We present simulations of
categorical enrichment based on multiple independent null
GWAS simulations using subjects with European ancestry from
the 1000 Genomes Project. Random phenotypes were generated
unrelated to genotypes for each subject, association z-scores were
computed for each tag SNP, and mean(z2) was computed for each
annotation category, using the same procedure as applied to the
actual GWAS data. The means and standard deviations were
computed from 20 independent simulation runs. The results
demonstrate that the observed differential enrichment of annota-
tion categories cannot be explained by category-specific spurious
sources of genomic inflation due to differential LD or MAF.
(DOCX)
Table S12 FDR versus sFDR Discovery. Leveraging the
enriched genic annotation categories to create strata among the
SNPs we show that the stratified false discovery rate (sFDR)
method improves the discovery of SNPs for a given FDR
threshold, across all phenotypes. The numbers reported are after
pruning SNPs for LD at a threshold of r2#0.2.
(XLSX)
Text S1 Supplementary text extending Materials and Methods
and presenting supporting analyses. More details are provided
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with respect to the acquisition, processing and annotating of the
GWAS data used for the main results. The relationship between
QQ-plots and False Discovery Rate is extended and related to our
measures of enrichment. Also, the main results are described
within the context of a mixture-modeling framework. Finally, a
series of control experiments are described and supplementary
references are enumerated.
(DOCX)
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